BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20562648)

  • 21. [A case of Denys-Drash syndrome with prophylactic bilateral nephrectomy].
    Yamamoto K; Santo Y; Satomura K
    Nihon Jinzo Gakkai Shi; 2003; 45(1):42-6. PubMed ID: 12680320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and pathological features of Denys-Drash syndrome: report of 3 cases].
    Wang HY; Sun LZ; Yue ZH; Yang J; Jiang XY; Mo Y
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):855-8. PubMed ID: 23302619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome.
    Little S; Hanks S; King-Underwood L; Picton S; Cullinane C; Rapley E; Rahman N; Pritchard-Jones K
    Pediatr Nephrol; 2005 Jan; 20(1):81-5. PubMed ID: 15503171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inherited WT1 mutation in Denys-Drash syndrome.
    Coppes MJ; Liefers GJ; Higuchi M; Zinn AB; Balfe JW; Williams BR
    Cancer Res; 1992 Nov; 52(21):6125-8. PubMed ID: 1327525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.
    Jeanpierre C; Denamur E; Henry I; Cabanis MO; Luce S; Cécille A; Elion J; Peuchmaur M; Loirat C; Niaudet P; Gubler MC; Junien C
    Am J Hum Genet; 1998 Apr; 62(4):824-33. PubMed ID: 9529364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.
    Pelletier J; Bruening W; Kashtan CE; Mauer SM; Manivel JC; Striegel JE; Houghton DC; Junien C; Habib R; Fouser L
    Cell; 1991 Oct; 67(2):437-47. PubMed ID: 1655284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel mutation of the WT1 gene (a tumor suppressor gene for Wilms' tumor) in a patient with Denys-Drash syndrome.
    Sakai A; Tadokoro K; Yanagisawa H; Nagafuchi S; Hoshikawa N; Suzuki T; Kohsaka T; Hasegawa T; Nakahori Y; Yamada M
    Hum Mol Genet; 1993 Nov; 2(11):1969-70. PubMed ID: 8281164
    [No Abstract]   [Full Text] [Related]  

  • 28. A novel WT1 gene mutation in a chinese girl with denys-drash syndrome.
    Wang F; Cai J; Wang J; He M; Mao J; Zhu K; Zhao M; Guan Z; Li L; Jin H; Shu Q
    J Clin Lab Anal; 2021 May; 35(5):e23769. PubMed ID: 33942367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype/phenotype correlations in Wilms' tumor.
    Huff V
    Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A familial WT1 mutation associated with incomplete Denys-Drash syndrome.
    Zhu C; Zhao F; Zhang W; Wu H; Chen Y; Ding G; Zhang A; Huang S
    Eur J Pediatr; 2013 Oct; 172(10):1357-62. PubMed ID: 23715653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion.
    Little MH; Williamson KA; Mannens M; Kelsey A; Gosden C; Hastie ND; van Heyningen V
    Hum Mol Genet; 1993 Mar; 2(3):259-64. PubMed ID: 8388765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A genetic childhood disease with consequences in adult life: the Denys-Drash syndrome].
    Löwik MM; van den Berkmortel FW; Noordam C; van Hamersvelt HW; van den Heuvel LP; Levtchenko EN
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1751-5. PubMed ID: 16114294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor.
    Cardoso LC; De Souza KR; De O Reis AH; Andrade RC; Britto AC; De Lima MA; Dos Santos AC; De Faria PS; Ferman S; Seuánez HN; Vargas FR
    Oncol Rep; 2013 Jan; 29(1):315-20. PubMed ID: 23117548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Glomerulopathy in Denys-Drash syndrome. Case report of a model disease].
    Stallmach T; Neuhaus TJ; Kösters R; Hailemariam S
    Pathologe; 1998 May; 19(3):230-4. PubMed ID: 9648150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An unusual presentation of Denys-Drash syndrome due to bigenic disease.
    Eneman B; Mekahli D; Audrezet MP; Lerut E; Van Damme-Lombaerts R; Van den Heuvel L; Levtchenko E
    Pediatrics; 2014 Jan; 133(1):e252-6. PubMed ID: 24379226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New mutation in WT1 gene in a boy with an incomplete form of Denys-Drash syndrome: A CARE-compliant case report.
    Akramov NR; Shavaliev RF; Osipova IV
    Medicine (Baltimore); 2021 May; 100(19):e25864. PubMed ID: 34106634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focal Segmental Membranoproliferative Glomerulonephritis: A Histological Variant of Denys-Drash Syndrome.
    Karmila AB; Yap YC; Appadurai M; Oh L; Fazarina M; Abd Ghani F; Ariffin H
    Fetal Pediatr Pathol; 2021 Apr; 40(2):113-120. PubMed ID: 31707902
    [No Abstract]   [Full Text] [Related]  

  • 39. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
    Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
    Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic bilateral nephrectomy and preemptive kidney transplantation for Denys-Drash syndrome prior to development of kidney failure.
    Hosokawa C; Hotta K; Okamoto T; Cho Y; Hirose T; Iwahara N; Manabe A; Shinohara N
    Pediatr Nephrol; 2024 Mar; 39(3):905-909. PubMed ID: 37572117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.